Physician profile
Seth Wardyn
NPI 1538724281
$14,893.29
in general payments reported to CMS, 2019-2025
8 companies · $9,126 in 2025
The $9,126 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.33 · 2024: $5,737 · 2025: $9,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $2,439 · Travel and Lodging: $1,859 · Education: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $2,439.29 |
| Travel and Lodging | $1,859.32 |
| Education | $594.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,101.98 | 2024-2025 | Firstpass, Spatial Frame, Acufex Meniscal Root Repair |
| Medical Device Business Services, INC. | $1,415.66 | 2024-2025 | Inhance |
| Arthrex, INC. | $1,270.72 | 2025 | |
| Depuy Synthes Sales INC. | $387.11 | 2024-2025 | Na, Tfn-Advance, Inhance |
| Stryker Corporation | $289.81 | 2023-2025 | Aequalis Flex Revive, Reunion, Triathlon |
| Zimmer Biomet Holdings, INC. | $200.47 | 2025 | Persona, Osseofit |
| Conetic Solutions, INC. | $188.74 | 2025 | |
| Blue Surgical LLC | $38.80 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Wardyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.